| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥263.1B | ¥250.7B | +5.0% |
| Operating Income | ¥27.4B | ¥23.3B | +17.5% |
| Ordinary Income | ¥23.0B | ¥19.9B | +15.5% |
| Net Income | ¥15.9B | ¥14.2B | +11.9% |
| ROE | 4.2% | 3.7% | - |
Daiichi Kigenso Kagaku Kogyo's FY2026 Q3 consolidated results show revenue of 26.3B yen (YoY +5.0%), operating income of 2.7B yen (YoY +17.5%), ordinary income of 2.3B yen (YoY +15.5%), and net income of 1.6B yen (YoY +11.9%). Gross profit margin improved to 29.2% from the prior year's 27.1%, while the operating margin reached 10.4%, indicating enhanced profitability. The company maintains a strong liquidity position with a current ratio of 316.0% and cash coverage of short-term debt at 3.05 times, though capital efficiency remains a concern with ROE at 4.2%. Short-term borrowings increased substantially from 30 million yen to 2.9B yen YoY, representing a notable shift in the funding structure. Full-year guidance targets revenue of 35.3B yen and operating income of 3.2B yen, with Q3 progress rates suggesting achievable targets.
Revenue growth of 5.0% YoY to 26.3B yen was primarily driven by improved pricing or product mix, as evidenced by the gross profit margin expansion from approximately 27.1% to 29.2%. Cost of sales increased 2.9% YoY to 18.6B yen, significantly lower than the revenue growth rate, indicating successful cost management or favorable input cost dynamics. Operating income increased 17.5% YoY to 2.7B yen, with the operating margin improving 1.1 percentage points to 10.4%, demonstrating strong operational leverage. SG&A expenses rose to 4.9B yen (18.8% of revenue), but grew slower than revenue, contributing to the margin expansion. Non-operating items resulted in a net deduction of approximately 440 million yen, comprising interest expenses of 351 million yen offset partially by non-operating income including dividend income and foreign exchange gains. Ordinary income of 2.3B yen represents a 15.5% YoY increase, though the gap between operating income (2.7B yen) and ordinary income (2.3B yen) reflects the burden of interest-bearing debt. Extraordinary items included investment securities sales gains of 267 million yen and impairment and disposal losses, resulting in profit before tax of 2.5B yen. The effective tax rate of approximately 35.9% reduced net income to 1.6B yen. Non-recurring factors include the investment securities sales gains and asset impairment/disposal losses, which together contributed approximately 100-200 million yen to net income. The company operates in a single segment (chemical manufacturing and sales), limiting segment-level analysis. This represents a revenue up, profit up pattern, with margin improvement driven by both top-line growth and enhanced operational efficiency.
[Profitability] ROE of 4.2% reflects limited capital efficiency, driven by net profit margin of 6.1%, asset turnover of 0.401, and financial leverage of 1.73 times. Operating margin of 10.4% improved 1.1 percentage points YoY from 9.3%, while gross profit margin reached 29.2%. The DuPont analysis reveals that low asset turnover is the primary constraint on ROE, attributable to extended working capital cycles. Interest coverage ratio stands at 7.79 times, indicating adequate earnings protection for interest obligations. [Cash Quality] Cash and deposits of 8.9B yen provide coverage of 3.05 times against short-term borrowings of 2.9B yen, ensuring strong short-term liquidity. However, working capital efficiency indicators show concern with days sales outstanding at 99 days, days inventory outstanding at 331 days, and cash conversion cycle at 408 days, reflecting protracted asset conversion to cash. [Investment Efficiency] Total asset turnover of 0.401 remains below the industry median of 0.56, indicating underutilization of assets. Inventory turnover of 331 days significantly exceeds the industry median of 112 days, suggesting excess inventory relative to sales velocity. Return on invested capital of approximately 3.8% warrants improvement. [Financial Health] Equity ratio of 57.8% provides a solid capital base, with debt-to-equity ratio of 0.73 times reflecting conservative leverage. Current ratio of 316.0% indicates abundant short-term solvency. Total interest-bearing debt of 17.5B yen represents a debt-to-capital ratio of 31.6%, remaining within investment-grade parameters.
Cash and deposits increased 19.2B yen YoY to 8.9B yen, reflecting accumulation despite the absence of detailed cash flow statement data for the quarterly period. The operating profit growth of 17.5% to 2.7B yen contributed to cash generation capacity, though extended working capital cycles with 408-day cash conversion suggest significant cash remains tied up in operations. Short-term borrowings increased dramatically by 2.9B yen YoY from 30 million yen to 2.9B yen, indicating either refinancing of long-term debt to short-term facilities or incremental working capital financing needs. Long-term loans decreased slightly to 14.6B yen from 14.9B yen, suggesting partial repayment or maturity transitions to short-term classification. The substantial cash coverage ratio of 3.05 times short-term debt indicates the company maintains adequate liquidity buffers despite the borrowing increase. Working capital changes show accounts payable management with payables days at a level that supports supplier credit utilization, though the 99-day receivables collection period and 331-day inventory holding period indicate room for efficiency gains that would release cash from operations.
Operating income of 2.7B yen versus ordinary income of 2.3B yen shows a net non-operating deduction of approximately 440 million yen, primarily comprising interest expenses of 351 million yen and other financial costs that exceeded non-operating income from dividends and foreign exchange. Non-operating income represents approximately 1.7% of revenue, consisting of interest and dividend income along with foreign exchange gains as primary components. Extraordinary items include investment securities sales gains of 267 million yen classified as non-recurring income, along with impairment losses and asset disposal costs that partially offset the gains. The presence of these non-recurring items means that approximately 100-200 million yen of the reported net income reflects one-time factors rather than sustainable operating performance. The effective tax rate of 35.9% is moderately elevated, with a tax burden coefficient of 0.642 in the DuPont analysis. While detailed operating cash flow data is unavailable for the quarterly period, the working capital indicators suggest that reported earnings face conversion challenges, with the 408-day cash conversion cycle indicating that accruals may temporarily exceed cash realization. The interest burden ratio of 0.909 (profit before tax to operating income) reflects the dilutive impact of net financial costs on earnings quality.
Progress versus full-year guidance shows revenue at 74.5% of the 35.3B yen target, operating income at 85.5% of the 3.2B yen target, and ordinary income at 95.9% of the 2.4B yen target through Q3. Revenue progress of 74.5% is slightly below the standard 75% Q3 benchmark, suggesting modest acceleration is needed in Q4 to achieve the full-year target. Operating income progress of 85.5% exceeds the standard 75% benchmark by 10.5 percentage points, indicating strong momentum and a high likelihood of surpassing the full-year operating income target of 3.2B yen. Ordinary income progress of 95.9% is substantially ahead of the 75% Q3 benchmark, driven by the non-recurring investment securities gains and favorable non-operating items in Q3, though Q4 ordinary income may moderate without similar one-time contributions. Net income guidance of 1.7B yen with forecast EPS of 70.16 yen implies Q4 net income of approximately 100 million yen, suggesting conservative Q4 profit assumptions. The company revised full-year operating income guidance upward 40.2% from the prior year, reflecting strong operational performance, while ordinary income guidance of 2.4B yen represents a 279.6% increase due to the low prior-year base affected by extraordinary losses. The operating margin expansion evident in Q3 supports the achievability of the 9.1% implied full-year operating margin (3.2B yen / 35.3B yen).
Annual dividend forecast is 14.00 yen per share for FY2026, comprising an interim dividend of 12.00 yen already paid and a planned year-end dividend of 14.00 yen, though this appears to represent a total annual dividend of 14.00 yen rather than 26.00 yen based on standard disclosure conventions. Using the 14.00 yen annual dividend figure, total dividend payments would amount to approximately 341 million yen based on 24.4 million outstanding shares. The payout ratio against forecast net income of 1.7B yen (70.16 yen EPS) yields approximately 39.7%, remaining within a sustainable range below 60%. Comparing to Q3 actual net income of 1.6B yen, the payout ratio would be approximately 42.3%, similarly sustainable. No share buyback activity is disclosed in the current period. The dividend policy appears stable with the forecast maintained at 14.00 yen. Cash reserves of 8.9B yen and strong current ratio of 316.0% provide ample coverage for dividend payments, supporting sustainability even with the elevated payout ratio. The total return ratio equals the payout ratio at approximately 40% in the absence of buybacks.
Working capital efficiency deterioration poses the primary risk, with days sales outstanding at 99 days, days inventory outstanding at 331 days, and cash conversion cycle at 408 days significantly exceeding industry norms. This structural inefficiency ties up approximately 29.6B yen in working capital (408 days × daily revenue of 72.5 million yen), constraining cash generation and requiring external financing despite profitable operations. The extended inventory turnover of 331 days compared to the industry median of 112 days represents 219 days of excess inventory, equivalent to approximately 15.9B yen of potential cash release if normalized. Short-term borrowing concentration risk increased substantially with short-term borrowings rising from 30 million yen to 2.9B yen YoY, representing an 8,667% increase. While current liquidity is strong, this shift introduces refinancing risk if credit conditions tighten or if the company cannot extend facilities at maturity. The borrowing increase suggests either working capital financing needs or debt maturity restructuring, warranting monitoring of borrowing terms and rollover capacity. Capital efficiency risk is evident in ROE of 4.2% and ROIC of approximately 3.8%, both substantially below typical cost of capital hurdle rates of 7-8%. This indicates that incremental investments are generating returns insufficient to create shareholder value, and the low asset turnover of 0.401 versus industry median of 0.56 highlights systemic underutilization of invested capital requiring operational improvements to justify continued capital deployment.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of 10.4% exceeds the manufacturing industry median of 8.9%, positioning the company in the upper quartile (industry IQR: 5.4-12.7%) and demonstrating competitive operational efficiency. Net profit margin of 6.1% approximates the industry median of 6.5%, indicating typical bottom-line conversion after tax and financial costs. ROE of 4.2% falls below the industry median of 5.8% (industry IQR: 3.1-8.4%), reflecting the company's capital efficiency challenges despite adequate profitability margins.
Efficiency: Asset turnover of 0.401 significantly underperforms the industry median of 0.56 (industry IQR: 0.41-0.65), ranking the company in the lower quartile and highlighting asset utilization as a key constraint. Inventory turnover of 331 days vastly exceeds the industry median of 112 days (industry IQR: 50-163 days), representing nearly three times the sector norm and indicating substantial excess inventory. Receivables turnover of 99 days exceeds the industry median of 85 days (industry IQR: 69-117 days), while operating working capital cycle of 408 days far surpasses the industry median of 112 days (industry IQR: 72-144 days), confirming structural working capital inefficiency.
Financial Health: Equity ratio of 57.8% approximates the industry median of 63.8% (industry IQR: 49.1-74.8%), indicating appropriate capital structure. Current ratio of 316.0% substantially exceeds the industry median of 287.0% (industry IQR: 213-384%), demonstrating superior short-term liquidity. Financial leverage of 1.73 times aligns with the industry median of 1.53 times (industry IQR: 1.31-1.86 times), reflecting balanced debt utilization.
Growth: Revenue growth of 5.0% YoY exceeds the industry median of 2.8% (industry IQR: -1.5% to 8.8%), positioning the company in the upper half of the peer group. EPS growth of 13.2% YoY substantially outperforms the industry median of 9.0% (industry IQR: -20% to 33%), demonstrating strong earnings momentum.
Overall, the company demonstrates competitive profitability and growth metrics but is constrained by materially inferior asset efficiency, particularly in working capital management. Addressing inventory and receivables turnover to industry-standard levels would substantially enhance capital efficiency and ROE performance.
(Industry: Manufacturing, N=105 companies, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Revenue and profit momentum remains positive with Q3 demonstrating 5.0% top-line growth and 17.5% operating income growth, supported by improving gross margins from approximately 27.1% to 29.2% and operating margin expansion to 10.4%. This trend indicates successful pricing power or favorable cost dynamics that enable the company to expand profitability faster than revenue growth. The operating margin of 10.4% exceeds the manufacturing industry median of 8.9%, confirming competitive operational performance. Full-year guidance achievement appears highly probable based on Q3 progress rates of 85.5% for operating income, suggesting potential for upward revision or outperformance.
Capital efficiency requires urgent attention with ROE at 4.2% below the industry median of 5.8% and ROIC at approximately 3.8% below value-creation thresholds. The primary driver is asset turnover of 0.401 versus industry median of 0.56, constrained by working capital cycles of 408 days compared to the industry median of 112 days. Specifically, inventory turnover of 331 days versus industry median of 112 days represents approximately 15.9B yen of excess capital tied up in inventory. Normalizing working capital to industry-standard efficiency would release substantial cash, reduce financing needs, and significantly improve ROE without requiring revenue growth. The recent increase in short-term borrowings from 30 million yen to 2.9B yen reflects financing of this working capital burden, with interest costs of 351 million yen annually diluting profitability.
Earnings quality reflects a combination of sustainable operational improvement and non-recurring items. Core operating performance improved with operating income up 17.5%, but approximately 100-200 million yen of net income derives from investment securities sales gains and other extraordinary items. The 95.9% progress rate for ordinary income versus the 3.2B yen full-year target suggests Q4 may show moderation as non-recurring gains do not repeat. Investors should focus on operating income and operating margin trends as more reliable indicators of business trajectory, with the sustainable earnings base closer to 1.4-1.5B yen annually versus the reported 1.6B yen Q3 net income. Strong liquidity with 8.9B yen cash and 316.0% current ratio provides cushion for dividend sustainability despite the 40% payout ratio, and supports the financial capacity to address working capital inefficiencies through operational initiatives rather than capital constraints.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.